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Objective: Atherosclerosis is an infl ammatory disease associated with an imbal-
ance between pro- and anti-infl ammatory mechanisms. While ample evidence is 
available in animal models, less is known about links between local vascular in-
fl ammation in human disease. T regulatory cells (Treg) have been implicated in 
atherosclerosis in mice but links with human vascular infl ammation are poorly 
understood. Accordingly, we aimed to investigate the relationship between T regs 
in peripheral blood and locally in perivascular adipose tissue (pVAT) with endo-
thelial function as a key mechanism in pathogenesis of vascular disease.
Design and method: Treg (CD3+/CD4+/CD25+/FoxP3+) infi ltration was studied in 
pVAT of atherosclerotic coronary artery (CORO), non-atherosclerotic internal mam-
mary artery (IMA), as well as subcutaneous AT and peripheral blood were quantifi ed 
using fl ow cytometry from 50 CABG patients (38 M;12F;age 65y+/-1) with typical ath-
erosclerosis risk factor profi le. Vascular function was assessed in IMA segments ex vivo 
by isometric tension studies of vasorelaxations to acetylcholine and ROS production 
was measured in vascular segments with 5uM lucigenin enhanced chemiluminescence.
Results: Treg infi ltration was observed in both IMA and CORO, but was sig-
nifi cantly higher in IMA pVAT than in pVAT surrounding CORO (13,58 ± 15,6 
vs. 4,74 ± 6,2 cells/mg; p < 0,01). Moreover, there was a signifi cant correlation 
between these two AT depots suggesting systemic pVAT regulation (R = +0,53; 
p = 0,001). Indeed we observed a signifi cant correlation between number of risk 
factors for atherosclerosis and Treg content (Rs = +0,33 p = 0,02). Importantly, 
there was an inverse correlation between Treg content in peripheral blood and 
Ach-induced vasorelaxations (R = –0,31 p < 0,05). Local T reg infi ltration in 
pVAT was signifi cantly correlated with indices of NO production, as measured by 
chemiluminescence (R = +0,58 p = 0,007). However, NO produced was scavenged 
by ROS (measured by ratio of L-NAME enhanced/basal superoxide levels) and 
Treg infi ltration in pVAT did not correlate with IMA endothelial function (R = 
–0.02 p = 0,92) or total vascular ROS production (R = –0,12 p = 0,53).
Conclusions: Atherosclerosis is accompanied by local decrease in T regulatory 
cell content in atherosclerotic vs. non-atherosclerotic arteries, although their 
amount is linked with classical risk factors for atherosclerosis. Higher peripheral 
blood T regs are associated with better endothelial function, although it is not 
achieved through locally infi ltrating Tregs.
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Objective: Left ventricular hypertrophy is common in hypertensive patients. In these 
subjects increased oxidative stress has been observed. Our aim was to evaluate the asso-
ciation of biomarkers of both oxidative stress and infl ammation with markers of cardio-
vascular damage in a large group of hypertensives with different stages of renal function.
Design and method: In 517 hypertensives we analyzed left ventricular mass in-
dexed for body surface area, and we assayed plasma levels of 8-isoprostaglandin 
F2a and high sensitivity C reactive protein.
Results: Multivariate analysis carried out considering left ventricular mass as depen-
dent variable, and including 8-isoprostaglandin F2, high sensitivity C reactive pro-
tein, age, sex, body mass index, estimated glomerular fi ltration rate, serum glucose, 
(log)triglycerides, hemoglobin, pulse pressure or systolic blood pressure, mean or 
diastolic blood pressure, and antihypertensive treatment showed that in hypertensives 
plasma levels of 8-isoprostaglandin F2 were correlated with left ventricular mass ( 
= 0.269, p < 0.0001). The bivariate relationship of left ventricular mass with 8-isopros-
taglandin F2a in hypertensives with estimated glomerular fi ltration rate higher and 
lower than 60 ml/min/1.73m2 was also calculated separately, demonstrating no signif-
icant differences in both correlations coeffi cients and slopes of the regression lines (r = 
0.254, p < 0.001 and r = 0.226, p < 0.002; respectively). In the overall group, receiver 
operating characteristic curves showed that 8-isoprostaglandin F2a and high sensitiv-
ity C reactive protein were predictors of left ventricular hypertrophy, p < 0.0001.
Conclusions: To the best of our knowledge, this is the fi rst demonstration that in 
hypertensives oxidative stress is correlated to left ventricular hypertrophy inde-
pendently of other confounding factors. Oxidative stress might participate in the 
development of hypertensive cardiac hypertrophy.
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Objective: Target organ damage (TOD) evaluation in patients with arterial hy-
pertension is necessary in order to estimate cardiovascular risk (CVR) and plan 
treatment. Increased carotid intima-media thickness (IMT), an index of TOD, rep-
resents the diffuse vascular atheromatosis. The integrity of endothelial glycocalyx 
(EG) plays a vital role in vascular permeability, infl ammation and elasticity and 
fi nally to cardiovascular disease. Sideview Darkfi eld imaging allows for non-in-
vasive automated estimation of EG dimensions based on the erythrocyte column 
distribution. We aimed to investigate any differences in EG levels in untreated 
patients with essential hypertension.
Design and method: We studied 86 patients with newly diagnosed and never 
treated essential hypertension (mean age 53+7 years, 53 males). Increased perfu-
sion boundary region (PBR) of the sublingual arterial microvessels (ranged from 
5–25 micrometers) using Sideview Darkfi eld imaging (Microscan, Glycocheck) 
was measured as a non-invasive accurate index of reduced EG thickness. We es-
timated carotid intima-media thickness using carotid ultrasonography (normal 
levels IMT < 0.8 mm).
Results: The whole population was divided in two groups regarding IMT levels, 
group A (IMT< 0.8 mm, n = 30, mean age 52+7 years, 17 males) and group B 
(IMT > 0.8 mm, n = 56, mean age 54+7 years, 36 males). Group A and B were 
also matched for age and sex. No differences were found within groups regard-
ing 24 h systolic and diastolic ABPM as well as PBR 5–25, PBR 10–19 and PBR 
20–25. We found that PBR 5–9 was increased in group B (1.19+0.1 vs. 1.13+0.1, 
p = 0.04) compared with group A.
Conclusions: EG dimensions are reduced in hypertensive patients with augment-
ed cardiovascular risk. Further studies are needed to confi rm our results in a larger 
population and possibly establish EG measurement as a new cardiovascular risk 
marker.
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Objective: To study whether reducing noradrenergic sympathetic vascular tone 
by doxazosin or blocking the renin-angiotensin-aldosterone system by ramipril 
will alter endothelial function in patients with uncomplicated hypertension.
Design and method: Mild-to-moderate hypertensive patients (age 54 ± 12 years, 
34% women, blood pressure (BP) 148 ± 11/88 ± 9 mmHg) were randomized 
double-blind to ramipril (10 mg od, n = 33) or doxazosin (8 mg od, n = 28) for 
12 weeks. Endothelium dependent and independent vasodilatation was studied by 
forearm post-ischemic fl ow mediated vasodilatation (FMD) and sublingual glyc-
eryl trinitrate (GTN), respectively; by the forearm skin microcirculation responses 
to acetylcholine (Ach) and sodium nitroprusside (SNP) applied by iontophoresis, 
respectively; and by endothelium dependent vasodilatation following beta 2-adre-
noceptor-agonist stimulation (sc terbutaline) assessed by the refl ection index from 
pulse wave analysis.
Results: Drug treatment reduced aortic and brachial BP, and reduced indices of 
aortic stiffness. The effects (mean ± SD or medians and interquartiles; and mean ± 
SEM; for delta week 0–12), by ramipril and doxazosin on FMD (5.3 ± 4.2 to 4.5 ± 
4.3%, delta -1.1 ± 1.0, and 6.3 ± 4.4 to 5.5 ± 3.1%, delta -0.3 ± 1.0); GTN (14.4 ± 
7.0 to 14.4 ± 6.9%, delta 0.3 ± 1.3, and 15.5 ± 6.8 to 14.4 ± 7.0, delta -0,5 ± 1.3); 
endothelial function index (ie FMD/GTN, 0.49 ± 0.56 to 0.44 ± 0.64, delta 0.07 ± 
0.12, and 0.47 ± 0.38 to 0.51 ± 0.41, delta 0.07 ± 0.12); and refl ection index (–6.8 
± 3.2 to –7.7 ± 3.8, delta –0.8 ± 1.0, and –7.3 ± 2.8 to –6.6 ± 3.1, delta 0.3 ± 0.9) 
were small. Also the effects by ramipril and doxazosin on skin microcirculation 
(peak fl ux, arbitrary units) were small: 33 [18–62] to 28 [19–53], delta -2 ± 5, and 
36 [21–62] to 41 [20–67], delta 1 ± 9 by Ach; and 46 [34–84] to 43 [26–87], delta 
–9 ± 8, and 58 [33–78] to 60 [44–82], delta –0.3 ± 10 by SNP; and 0.5 [0.4–1.0] to 
0.8 [0.4–1.3], delta 0.2 ± 0.2, and 0.6 [0.4–1.0] to 0.8 [0.3–1.4], delta 0.3 ± 10 by 
the peak fl ux ratio (Ach/SNP), respectively. Also skin microcirculatory responses 
to heat induced hyperemia remained unchanged.
Conclusions: ACE-inhibition and alpha 1-adrenoceptor-blockade for 12 
weeks reduce BP and improve indices of aortic stiffness but appear to have 
no effects on endothelial function assessed in multiple ways in mild-to moder-
ate uncomplicated hypertension. Evidence of endothelial dysfunction and the 
potential benefi t of treatment might require more advanced stages of hyper-
tensive disease.
